Israel’s OCON Therapeutics (see here previously) develops, manufactures and markets women’s health products based on its patented, non-invasive, intrauterine therapy delivery technology. 85% of OCON’s workforce are women. Pipeline treatments include fibroids & abnormal bleeding.
https://www.israel21c.org/new-drug-delivery-stent-could-revolutionize-womens-health/